Niddk: to acquire illumina reagents and consumables
Ended Awarded Last action
- Contract number
- 75N94020F00005
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $122,354
Award facts
- Contract value 100% obligated
- $122,354.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$307 | |
| Supplemental Agreement for work within scope | -$134 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | -$14,753 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $137,548 |
About this award
The U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a Firm Fixed Price Delivery Order contract to Illumina, Inc. to acquire Illumina sequencing reagents and consumables. The contract has a ceiling value of $122,354.40 and runs through September 30, 2022. Illumina is a manufacturer of genetic and genomic analysis instruments and reagents, and has previously provided sequencing systems and related products to support research and diagnostics across various federal agencies. This award is not associated with a set-aside program. Illumina has an Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery to provide reagents and controls for its sequencing platforms used in biological threat characterization.
Quick answers
Who was awarded contract 75N94020F00005?
75N94020F00005 was awarded to Illumina, Inc. by National Institute of Child Health and Human Development (National Institutes of Health) on June 19, 2020.
How much is contract 75N94020F00005 worth?
The government has obligated $122,354 on 75N94020F00005.
Which agency awarded contract 75N94020F00005?
National Institute of Child Health and Human Development (National Institutes of Health) awarded 75N94020F00005, with funding from National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health).
Is contract 75N94020F00005 an order under another contract?
Yes. 75N94020F00005 is a delivery order under HHSN268201500004I, an indefinite delivery contract.
Was contract 75N94020F00005 competed?
The extent of competition for 75N94020F00005 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award